[Fibrate-induced changes in the serum lipid contents of individual C16 and C18 fatty acids in patients with hyperlipidemia].
Titov
V N
VN
Arapbaeva
A A
AA
Kukharchuk
V V
VV
Balakina
M V
MV
Tishinin
M A
MA
Ameliushkina
V A
VA
D005227:Fatty Acids / Q000097:blood*; D015248:Gemfibrozil / Q000627:therapeutic use*; D006801:Humans; D006949:Hyperlipidemias / Q000097:blood / Q000188:drug therapy*; D000960:Hypolipidemic Agents / Q000627:therapeutic use*; D019787:Linoleic Acid / Q000097:blood; D008055:Lipids / Q000097:blood* / Q000737:chemistry; D019301:Oleic Acid / Q000097:blood; D019308:Palmitic Acid / Q000097:blood; D044967:Serum; D013229:Stearic Acids / Q000097:blood
D005227:Fatty Acids; D000960:Hypolipidemic Agents; D008055:Lipids; D013229:Stearic Acids; D019301:Oleic Acid; D019308:Palmitic Acid; C031183:stearic acid; D019787:Linoleic Acid; D015248:Gemfibrozil